Re: Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program J. J. Tosoian, S. Loeb, A. Kettermann, P. Landis, D. J. Elliot, J. I. Epstein, A. W. Partin, H. B. Carter and L. J. Sokoll J Urol 2010; 183: 534-538.
Papatsoris
Athanasios
A
Bourdoumis
Andreas
A
Chrisofos
Michael
M
D000951:Antigens, Neoplasm / Q000652:urine*; D001706:Biopsy; D051517:Digital Rectal Examination; D018450:Disease Progression; D006801:Humans; D008297:Male; D049451:Nomograms; D011159:Population Surveillance; D011237:Predictive Value of Tests; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000652:urine*; D012107:Research Design; D013048:Specimen Handling
D000951:Antigens, Neoplasm; C479341:prostate cancer antigen 3, human